Monitoring cell endocytosis of liposomes by real-time electrical impedance spectroscopy

Anal Bioanal Chem. 2020 Sep;412(24):6371-6380. doi: 10.1007/s00216-020-02592-x. Epub 2020 May 25.

Abstract

Evaluation and understanding the effect of drug delivery in in vitro systems is fundamental in drug discovery. We present an assay based on real-time electrical impedance spectroscopy (EIS) measurements that can be used to follow the internalisation and cytotoxic effect of a matrix metalloproteinase (MMP)-sensitive liposome formulation loaded with oxaliplatin (OxPt) on colorectal cancer cells. The EIS response identified two different cellular processes: (i) a negative peak in the cell index (CI) within the first 5 h, due to onset of liposome endocytosis, followed by (ii) a subsequent CI increase, due to the reattachment of cells until the onset of cytotoxicity with a decrease in CI. Free OxPt or OxPt-loaded Stealth liposomes did not show this two-stage EIS response; the latter can be due to the fact that Stealth cannot be cleaved by MMPs and thus is not taken up by the cells. Real-time bright-field imaging supported the EIS data, showing variations in cell adherence and cell morphology after exposure to the different liposome formulations. A drastic decrease in cell coverage as well as rounding up of cells during the first 5 h of exposure to OxPt-loaded (MMP)-sensitive liposome formulation is reflected by the first negative EIS response, which indicates the onset of liposome endocytosis. Graphical abstract.

Keywords: Cell morphology; Cytotoxicity; Electrical impedance spectroscopy; Liposome endocytosis; Matrix metalloproteinase; Real-time monitoring.

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacology
  • Cell Line, Tumor
  • Colorectal Neoplasms / drug therapy
  • Dielectric Spectroscopy
  • Endocytosis*
  • Humans
  • Liposomes*
  • Oxaliplatin / administration & dosage*
  • Oxaliplatin / pharmacology

Substances

  • Antineoplastic Agents
  • Liposomes
  • Oxaliplatin